Insider Transactions in Q1 2025 at Charles River Laboratories International, Inc. (CRL)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 25
2025
|
Birgit Girshick Corporate Executive VP & COO |
SELL
Bona fide gift
|
Direct |
430
-0.78%
|
-
|
|
Feb 20
2025
|
James C Foster Chairman, President and CEO |
BUY
Open market or private purchase
|
Direct |
6,075
+3.2%
|
$1,002,375
$165.01 P/Share
|
|
Feb 20
2025
|
Joseph W La Plume EVP, Corp Strategy & Develop |
SELL
Open market or private sale
|
Direct |
4,400
-18.02%
|
$712,800
$162.5 P/Share
|
|
Feb 20
2025
|
Birgit Girshick Corporate Executive VP & COO |
BUY
Open market or private purchase
|
Direct |
1,514
+2.68%
|
$248,296
$164.63 P/Share
|
|
Jan 31
2025
|
Flavia Pease Corporate Executive VP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
914
-7.33%
|
$150,810
$165.57 P/Share
|
|
Jan 31
2025
|
Flavia Pease Corporate Executive VP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
2,704
+17.83%
|
-
|
|
Jan 31
2025
|
James C Foster Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,827
-3.34%
|
$1,126,455
$165.57 P/Share
|
|
Jan 31
2025
|
James C Foster Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
19,608
+8.75%
|
-
|
|
Jan 31
2025
|
Joseph W La Plume EVP, Corp Strategy & Develop |
SELL
Payment of exercise price or tax liability
|
Direct |
846
-3.35%
|
$139,590
$165.57 P/Share
|
|
Jan 31
2025
|
Joseph W La Plume EVP, Corp Strategy & Develop |
BUY
Grant, award, or other acquisition
|
Direct |
2,738
+9.78%
|
-
|
|
Jan 31
2025
|
Shannon M Parisotto CEVP, Disc & Safety Assessment |
SELL
Payment of exercise price or tax liability
|
Direct |
471
-4.97%
|
$77,715
$165.57 P/Share
|
|
Jan 31
2025
|
Shannon M Parisotto CEVP, Disc & Safety Assessment |
BUY
Grant, award, or other acquisition
|
Direct |
1,758
+15.66%
|
-
|
|
Jan 31
2025
|
Victoria L Creamer EVP & Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
791
-4.57%
|
$130,515
$165.57 P/Share
|
|
Jan 31
2025
|
Victoria L Creamer EVP & Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,468
+12.49%
|
-
|
|
Jan 31
2025
|
Michael Gunnar Knell CSVP&Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
282
-3.09%
|
$46,530
$165.57 P/Share
|
|
Jan 31
2025
|
Michael Gunnar Knell CSVP&Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
811
+8.15%
|
-
|
|
Jan 31
2025
|
Birgit Girshick Corporate Executive VP & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,025
-1.88%
|
$169,125
$165.57 P/Share
|
|
Jan 31
2025
|
Birgit Girshick Corporate Executive VP & COO |
BUY
Grant, award, or other acquisition
|
Direct |
4,057
+6.92%
|
-
|